Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J B Ulmer

Showing results (51-60 of 75) with videos related to

Pageof 8
Sort By:
Intervirology|March 17, 2001
Relative potency of cellular and humoral immune responses induced by DNA vaccinationG R Otten, B Doe, M Schaefer, et al.
Nature Medicine|June 1, 1995
Preclinical efficacy of a prototype DNA vaccine: enhanced protection against antigenic drift in influenza virusJ J Donnelly, A Friedman, D Martinez, et al.
Cellular and Molecular Biology (Noisy-Le-Grand, France)|May 1, 1997
Induction of humoral and cellular immune responses by vaccination with M. tuberculosis antigen 85 DNAD L Montgomery, K Huygen, A M Yawman, et al.
Journal of Virology|September 5, 2001
Induction of potent immune responses by cationic microparticles with adsorbed human immunodeficiency virus DNA vaccinesD O'Hagan, M Singh, M Ugozzoli, et al.
Vaccine|June 1, 1997
Expression and immunogenicity of Mycobacterium tuberculosis antigen 85 by DNA vaccinationJ B Ulmer, M A Liu, D L Montgomery, et al.
Hepatology (Baltimore, Md.)|May 29, 2000
Priming of hepatitis C virus-specific cytotoxic T lymphocytes in mice following portal vein injection of a liver-specific plasmid DNAA Y Lee, W C Manning, C L Arian, et al.
Advances in Experimental Medicine and Biology|January 1, 1996
DNA vaccines for bacteria and virusesJ B Ulmer, R R Deck, A Yawman, et al.
Vaccine|January 29, 2000
Enhanced type I immune response to a hepatitis B DNA vaccine by formulation with calcium- or aluminum phosphateS Wang, X Liu, K Fisher, et al.
Novartis Foundation Symposium|February 9, 1999
DNA vaccines against tuberculosisJ B Ulmer, D L Montgomery, A Tang, et al.
Molecular Medicine (Cambridge, Mass.)|June 1, 1997
Priming of cytotoxic T lymphocytes by DNA vaccines: requirement for professional antigen presenting cells and evidence for antigen transfer from myocytesT M Fu, J B Ulmer, M J Caulfield, et al.
Pageof 8

Showing results (51-60 of 75) with videos related to

Sort By:
Pageof 8
Intervirology|March 17, 2001
Relative potency of cellular and humoral immune responses induced by DNA vaccinationG R Otten, B Doe, M Schaefer, et al.
Nature Medicine|June 1, 1995
Preclinical efficacy of a prototype DNA vaccine: enhanced protection against antigenic drift in influenza virusJ J Donnelly, A Friedman, D Martinez, et al.
Cellular and Molecular Biology (Noisy-Le-Grand, France)|May 1, 1997
Induction of humoral and cellular immune responses by vaccination with M. tuberculosis antigen 85 DNAD L Montgomery, K Huygen, A M Yawman, et al.
Journal of Virology|September 5, 2001
Induction of potent immune responses by cationic microparticles with adsorbed human immunodeficiency virus DNA vaccinesD O'Hagan, M Singh, M Ugozzoli, et al.
Vaccine|June 1, 1997
Expression and immunogenicity of Mycobacterium tuberculosis antigen 85 by DNA vaccinationJ B Ulmer, M A Liu, D L Montgomery, et al.
Hepatology (Baltimore, Md.)|May 29, 2000
Priming of hepatitis C virus-specific cytotoxic T lymphocytes in mice following portal vein injection of a liver-specific plasmid DNAA Y Lee, W C Manning, C L Arian, et al.
Advances in Experimental Medicine and Biology|January 1, 1996
DNA vaccines for bacteria and virusesJ B Ulmer, R R Deck, A Yawman, et al.
Vaccine|January 29, 2000
Enhanced type I immune response to a hepatitis B DNA vaccine by formulation with calcium- or aluminum phosphateS Wang, X Liu, K Fisher, et al.
Novartis Foundation Symposium|February 9, 1999
DNA vaccines against tuberculosisJ B Ulmer, D L Montgomery, A Tang, et al.
Molecular Medicine (Cambridge, Mass.)|June 1, 1997
Priming of cytotoxic T lymphocytes by DNA vaccines: requirement for professional antigen presenting cells and evidence for antigen transfer from myocytesT M Fu, J B Ulmer, M J Caulfield, et al.
Pageof 8